Melatonin and Quality of Life
Abstract
There is substantial evidence that fragmented sleep, delayed sleep phase syndrome (DSPS), insomnia, and impaired daytime alertness are the result of disorders in brain functioning that are closely linked to disruptions in the regulation of circadian rhythms. In children suffering from neurodevelopmental disabilities, such as attention deficit hyperactivity disorder (ADHD) and epilepsy, sleep disturbance and behavioral problems are significant correlated symptoms. There is also evidence that by addressing these problems directly, significant improvements can be made in the quality of life (QOL) experienced by the affected individuals. Children with ADHD exhibit impairments in the circadian pacemaker as shown by studies confirming an associated delay in the peak melatonin output under dim light conditions. Therapy involving melatonin administration to these children not only improves their sleep onset and efficiency but also improves their health status and QOL. The QOL of young adults who suffer from DSPS is significantly impaired by the resulting symptoms of insomnia and tiredness. Treatment of DSPS patients with melatonin has been reported to improve QOL dimensions such as physical functioning, mental health, and emotional well-being, as well as social functioning and general health. In patients suffering from chronic fatigue syndrome, melatonin improved QOL by enhancing vitality and energy and by reducing pain perception and fatigue. Melatonin has also been demonstrated to…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.